EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbiota and IBD: Current knowledge and future perspectives

Caterina Foppa, Tommy Rizkala, Alessandro Repici, Cesare Hassan, Antonino Spinelli

Digestive and Liver Disease · 2024-06 · 56 (6) · 911-922

DOI: 10.1016/j.dld.2023.11.015 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Digestive and Liver Disease, 2024-06. Verfasst von Caterina Foppa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090, Milan, Italy; IRCCS Humanitas Research Ho…. Hauptthemen laut MEDLINE: Dysbiosis, Inflammatory Bowel Diseases, Gastrointestinal Microbiome. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 126 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory Bowel Disease (IBD) is a chronic relapsing-remitting disease with a remarkable increase in incidence worldwide and a substantial disease burden. Although the pathophysiology is not fully elucidated yet an aberrant immune reaction against the intestinal microbiota and the gut microbial dysbiosis have been identified to play a major role. The composition of gut microbiota in IBD patients is distinct from that of healthy individuals, with certain organisms predominating over others. Differences in the microbial dysbiosis have been also observed between Crohn Disease (CD) and Ulcerative Colitis (UC). A disruption of the microbiota's balance can lead to inflammation and intestinal damage. Microbiota composition in IBD can be affected both by endogenous (i.e., interaction with the immune system and intestinal epithelial cells) and exogenous (i.e., medications, surgery, diet) factors. The complex interplay between the gut microbiota and IBD is an area of great interest for understanding disease pathogenesis and developing new treatments. The purpose of this review is to summarize the latest evidence on the role of microbiota in IBD pathogenesis and to explore possible future areas of research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysbiosisInflammatory Bowel DiseasesGastrointestinal MicrobiomeHumansCrohn DiseaseColitis, UlcerativeProbioticsMicrobiota

Stichwörter der Autor:innen

DietDysbiosisIBDMedicationsMicrobiomeMicrobiome interactionsSurgeryTarget therapy

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090, Milan, Italy; IRCCS Humanitas Research Hospital, Division of Colon and Rectal Surgery, via Manzoni 56, Rozzano,…
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20090, Milan, Italy; IRCCS Humanitas Research Hospital, Division of Gastroenterology and Digestive Endoscopy Unit, via…

Zitieren

APA

Foppa, C., Rizkala, T., Repici, A., Hassan, C., & Spinelli, A. (2024). Microbiota and IBD: Current knowledge and future perspectives. Digestive and Liver Disease, 56(6), 911-922. https://doi.org/10.1016/j.dld.2023.11.015

Vancouver

Foppa C, Rizkala T, Repici A, Hassan C, Spinelli A. Microbiota and IBD: Current knowledge and future perspectives. Digestive and Liver Disease. 2024;56(6):911-922. doi:10.1016/j.dld.2023.11.015

BibTeX
@article{Foppa2024,
  author = {Foppa, Caterina and Rizkala, Tommy and Repici, Alessandro and Hassan, Cesare and Spinelli, Antonino},
  title = {Microbiota and IBD: Current knowledge and future perspectives},
  journal = {Digestive and Liver Disease},
  year = {2024},
  volume = {56},
  number = {6},
  pages = {911--922},
  doi = {10.1016/j.dld.2023.11.015}
}
Kostenlos starten →